The results of survival tests revealed that the high expression of GPC3, UBE2C, E2F1, and CDC20 had a correlation with a shorter total survival in HCC patients (Figures 7(a) and 7(b)). This evidence concerns the gene E2F1 and hepatocellular carcinoma.